Asset Management One Co. Ltd. Has $26.46 Million Position in HCA Healthcare, Inc. (NYSE:HCA)

Asset Management One Co. Ltd. grew its position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 1.4% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The firm owned 76,561 shares of the company's stock after purchasing an additional 1,035 shares during the period. Asset Management One Co. Ltd.'s holdings in HCA Healthcare were worth $26,456,000 at the end of the most recent reporting period.

Several other hedge funds also recently bought and sold shares of the company. Congress Wealth Management LLC DE boosted its holdings in shares of HCA Healthcare by 3.4% during the 4th quarter. Congress Wealth Management LLC DE now owns 1,039 shares of the company's stock worth $312,000 after buying an additional 34 shares during the period. Evergreen Private Wealth LLC boosted its holdings in shares of HCA Healthcare by 0.3% during the 4th quarter. Evergreen Private Wealth LLC now owns 12,787 shares of the company's stock worth $3,838,000 after buying an additional 35 shares during the period. Whittier Trust Co. boosted its holdings in HCA Healthcare by 3.6% in the 4th quarter. Whittier Trust Co. now owns 1,195 shares of the company's stock valued at $359,000 after purchasing an additional 41 shares during the period. Barden Capital Management Inc. boosted its holdings in HCA Healthcare by 1.4% in the 1st quarter. Barden Capital Management Inc. now owns 2,921 shares of the company's stock valued at $1,009,000 after purchasing an additional 41 shares during the period. Finally, Coldstream Capital Management Inc. boosted its holdings in HCA Healthcare by 1.3% in the 4th quarter. Coldstream Capital Management Inc. now owns 3,471 shares of the company's stock valued at $1,042,000 after purchasing an additional 44 shares during the period. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of research firms have issued reports on HCA. Baird R W downgraded shares of HCA Healthcare from a "strong-buy" rating to a "hold" rating in a report on Tuesday, April 15th. Robert W. Baird restated a "neutral" rating and issued a $336.00 target price (down from $396.00) on shares of HCA Healthcare in a research report on Tuesday, April 15th. Barclays set a $416.00 target price on shares of HCA Healthcare and gave the company an "overweight" rating in a research report on Monday, June 2nd. Wells Fargo & Company upgraded shares of HCA Healthcare from an "underweight" rating to an "equal weight" rating and boosted their target price for the company from $320.00 to $385.00 in a research report on Thursday, May 29th. Finally, Guggenheim began coverage on shares of HCA Healthcare in a research report on Wednesday, April 9th. They issued a "neutral" rating for the company. Seven research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $394.33.

Insider Activity

In related news, COO Jon M. Foster sold 15,698 shares of the stock in a transaction on Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the transaction, the chief operating officer now directly owns 12,646 shares of the company's stock, valued at $4,670,420.72. This represents a 55.38% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 1.30% of the company's stock.

HCA Healthcare Trading Up 0.1%

HCA opened at $379.06 on Wednesday. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $417.14. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.19 and a quick ratio of 1.06. The firm has a market capitalization of $91.19 billion, a price-to-earnings ratio of 16.85, a PEG ratio of 1.31 and a beta of 1.49. The company's 50 day moving average price is $363.94 and its two-hundred day moving average price is $335.66.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its earnings results on Friday, April 25th. The company reported $6.45 earnings per share for the quarter, topping analysts' consensus estimates of $5.75 by $0.70. HCA Healthcare had a net margin of 8.07% and a return on equity of 1,063.91%. The firm had revenue of $18.32 billion for the quarter, compared to analyst estimates of $18.26 billion. During the same period in the previous year, the firm posted $5.36 EPS. The company's revenue for the quarter was up 5.7% compared to the same quarter last year. As a group, research analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, June 30th. Stockholders of record on Monday, June 16th will be paid a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.76%. The ex-dividend date is Monday, June 16th. HCA Healthcare's dividend payout ratio is currently 12.81%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.